In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat
- PMID: 9666467
In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat
Abstract
We report our comparative studies of myo- and chiro-[3H]inositol distribution in control nondiabetic Wistar and spontaneous nonobese insulin-resistant Type II diabetic G.K. rat tissues following 78-h labeling period. From various tissue extracts, free inositols, inositol phosphates, and inositol phospholipids were isolated and analyzed. Our findings demonstrate (1) a significant difference in the metabolism of myo- and chiro-inositol in normal Wistar and G.K. rats, (2) a severe defect in conversion of myo-[3H]inositol to chiro-[3H]inositol at the inositol phospholipid level of insulin-sensitive tissues of the G.K. rat, (3) an increased incorporation of myo-[3H]inositol into purified inositol phospholipids of the G.K. rat consistent with a decreased conversion to chiro-[3H]inositol, (4) the presumed presence of a pathway which incorporates chiro-[3H]inositol into inositol phospholipids, and which is overactive in the G.K. rat compared to the Wistar rat, and (5) no or minimal conversion of chiro-[3H]inositol to myo-[3H]inositol.
Similar articles
-
Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor.Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7759-63. doi: 10.1073/pnas.90.16.7759. Proc Natl Acad Sci U S A. 1993. PMID: 8356081 Free PMC article.
-
Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.Biochem Biophys Res Commun. 2002 May 10;293(3):1092-8. doi: 10.1016/S0006-291X(02)00313-3. Biochem Biophys Res Commun. 2002. PMID: 12051772
-
Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11040-4. doi: 10.1073/pnas.91.23.11040. Proc Natl Acad Sci U S A. 1994. PMID: 7972005 Free PMC article.
-
Potential role and therapeutic interests of myo-inositol in metabolic diseases.Biochimie. 2013 Oct;95(10):1811-27. doi: 10.1016/j.biochi.2013.05.011. Epub 2013 Jun 10. Biochimie. 2013. PMID: 23764390 Review.
-
From Myo-inositol to D-chiro-inositol molecular pathways.Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2390-2402. doi: 10.26355/eurrev_202103_25279. Eur Rev Med Pharmacol Sci. 2021. PMID: 33755975 Review.
Cited by
-
D-chiro-inositol negatively regulates the formation of multinucleated osteoclasts by down-regulating NFATc1.J Clin Immunol. 2012 Dec;32(6):1360-71. doi: 10.1007/s10875-012-9722-z. Epub 2012 Jun 19. J Clin Immunol. 2012. PMID: 22711011
-
Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome.Metab Syndr Relat Disord. 2010 Apr;8(2):127-36. doi: 10.1089/met.2009.0052. Metab Syndr Relat Disord. 2010. PMID: 20156067 Free PMC article. Clinical Trial.
-
D-chiro-inositol glycans in insulin signaling and insulin resistance.Mol Med. 2010 Nov-Dec;16(11-12):543-52. doi: 10.2119/molmed.2010.00107. Epub 2010 Aug 27. Mol Med. 2010. PMID: 20811656 Free PMC article. Review.
-
Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes.Nutrients. 2019 Sep 30;11(10):2314. doi: 10.3390/nu11102314. Nutrients. 2019. PMID: 31574903 Free PMC article. Review.
-
Inositol and antioxidant supplementation: Safety and efficacy in pregnancy.Diabetes Metab Res Rev. 2019 Jul;35(5):e3154. doi: 10.1002/dmrr.3154. Epub 2019 Apr 10. Diabetes Metab Res Rev. 2019. PMID: 30889626 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources